Causes of nausea at EOL
GI Factors:
Meds:
Metabolic
Cranial
Psychosomatic
- Anxiety, pain, anticipator nausea
Pathophysiology of emesis - Chemoreceptor Trigger Zone
Chemoreceptor Trigger Zone (area postrema in fourth ventricle)
- No blood brain barrier - Bathed in CSF with chemoreceptors (D2, serotonin, and cannabinoid) responsive to drugs and electrolytes - Relays neurotransmitters to Vomiting Centre and vomiting reflex
Pathophysiology of Emesis - Vomiting Centre
Vomiting Centre is a diffuse network in the medulla oblongata of the mid brainstem
- Nausea without vomiting may be due to stimulation of the VC without enough amplification to trigger the vomiting cascade - H1, acetylcholine, serotonin receptors - Input from the CTZ, vestibular apparatus and cerebellum, higher cortex, gut chemoreceptors and mechanoreceptors, mechanoreceptors in viscera/serosa (head and neck, thorax, abdomen, pelvis) - Stimulation causes parasympathetic and sympathetic output as well as neurotransmitter cascade to induce vomiting
Inputs to Vomiting Centre
CTZ (area postrema in fourth ventricle)
- D2, serotonin 5-HT3, opioid receptors, acetylcholine receptors, substance P reeptors
Vestibular system (via CN 8 - vestibulocochlear), motion sickness - muscarinic and H1 receptors
CN X (vagal nerve) - pharyngeal irritation (gag reflex)
Vagal and enteric nervous system (chemoreceptors, mechanoreceptors in gut, mechanoreceptors from viscera/serosa), D2 and Serotonin
CNS (psychiatric disorders, stress), H1 receptor
Approach to Nausea/Vomiting
Rx for Opioid nausea, neurotransmitter and site
Rx for Gastric stasis, Ileus, neurotransmitter and site
Rx for Gastric Obstruction, neurotransmitter and site
Rx for Chemotherapy nausea, neurotransmitter and site
**Check guidelines from ASCO for this
Also consider haldol, and olanzapine 5-10mg q daily on days before and during chemo has been found to be effective, though evidence may be poor.
Rx for raised ICP nausea, neurotransmitter and site
-Use Phenothiazines (prochlorperazine 5-10mg/12.5-25m IM q8H) along with Dex for decreasing ICP
Maxeran for Nausea (indications, dose, side effects, notes)
Metoclopramide 10-20mg PO/SC/IV q4H
CTZ and GI tract, D2. Note that metoclopramide potentiates 5-HT3 receptors (may be used with ondansetron, but watch QT) and can act on 5-HT3 at higher doses. Central antiemetic effect plus prokinetic effect and decreased pylorus activity - food passes through more quickly.
Indications: Gastric stasis, ileus (avoid in complete obstruction), may use for Chemotherapy
Do not combine with anticholinergics (scopolamine, hyoscine, diphenhydramine) due to counteracting effects. Note that olanzapine, levomepromazine also have anticholingeric effects and increase risk of EPS.
Side effects: EPS, restlessness, drowsiness, colic in GI obstruction. Risk of tardive dyskinesia, especially if used longer than 12 weeks, at higher doses, or in patients under 20 years old. Risk increased with combination with antipsychotics!
Prolonged half life in renal failure, long QTc. Caution in Parkison’s (may worsen symptoms as a dopamine antagonist)
EPS with anti-nauseants - symptoms, pathophys, agents
Symptoms: Parkinsonism, dystonia, tardive dyskinesia, akathisia
Seen with Maxeran and prochlorperazine overdose (usually but not always reversible)
Levomepromazine for nausea (indications, dose, side effects, notes)
5-12mg PO/SC over 24 hrs (BID or continuous SC infusion)
Receptors: D2, 5HT2, H1, acting on VC
Indications: Intestinal obstruction, peritoneal irritation, vestibular, raised ICP, unknown causes
Side effects: Long QTc, sedating, orthostasis, anticholinergic effects (esp in elderly) - confusion, hallucinations, EPS
Non-pharm measures for nausea
Citrus Ginger Peppermint Cold, lightly carbonated beverages Hydration Decrease odours
Glucocorticoids for nausea (indications, dose, side effects, notes)
Exact mechanism unknown, likely glucocorticoid receptors in central nucleus.
Dexamethasone 4-8 mg PO qAm (higher doses if related to increased ICP)
Side effects: Hyperglycemia, Cushing syndrome, weight gain, PUD, infection, aseptic necrosis (femoral/humerol heads), impaired wound healing, steroid psychosis, adrenal suppression,
Pearls:
Combinations to avoid
Prokinetics (maxeran) and anticholinergics (dimenhydrinate, scopolamine) as combination is illogical
Maxeran with antipsychotics (increased risk of EPS)
Cannabis for nausea - evidence
No controlled clinical efficacy studies
Nabilone
Antiemetic alternative
Nabilone 0.25 - 2mg PO BID (start low)
Acts on cannabinoid receptors (CB1) in CNS
Side effects: Drowsiness, dizziness, vertigo, euophoria, ataxia, xerosteomia
Approach to opioid nausea
Epidemiology of Nausea and Vomiting (cancer)
Occurs in 50-70% of patients with advanced cancer
Epidemiology of Nausea and Vomiting (AIDS)
43 - 49% of patients with AIDS
Epidemiology of Nausea and Vomiting (ESRD)
30 - 43% ESRD
Epidemiology of Nausea and Vomiting (Advanced cardiac disease)
17 - 48% Advanced Cardiac Disease